Epsilon Healthcare Ltd (ASX: EPN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Epsilon Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $7.21 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 300.35 million
Earnings per share -0.011
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Epsilon Healthcare Ltd (ASX: EPN)
    Latest News

    Back view of a man lifting hish hands high in front of hemp plants grown for cannabis.
    Cannabis Shares

    Epsilon Healthcare (ASX:EPN) share price rockets 24% on new agreement

    Scientists are still unlocking the full potential of medicinal marijuana.

    Read more »

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    Why the Epsilon (ASX:EPN) share price is soaring 16% today

    After going into a trading halt on Monday, the microcap ASX cannabis company has made an announcement today.

    Read more »

    Share Gainers

    ASX pot stocks have been skyrocketing in December

    Recent global events have caused the share prices of many ASX pot stocks to skyrocket. Let's take a closer look.

    Read more »

    little green pharma share price represented by cannabis leaf character jumping cheerfully
    Share Market News

    ASX stock of the day: Elixinol Global (ASX:EXL) shares blaze new highs

    Elixinol Global Ltd (ASX: EXL) shares are blazing higher today, up more than 55%. Here's why this ASX cannabis company…

    Read more »

    Falling asx share price represented by man in chinos falling suspended in mid-air
    Share Market News

    Here's why ASX cannabis shares are falling today

    Here's why Cann Group Ltd (ASX: CAN) and other ASX cannabis shares are giving investors a headache today. It's got…

    Read more »

    Share Fallers

    The Cann Group share price getting smoked after a strategic shareholder exits

    The Cann Group Ltd (ASX: CAN) share price got smoked today on news that a major shareholder and partner sold…

    Read more »

    Share Fallers

    Why Northern Star, SeaLink, THC Global, & Whitehaven Coal shares are dropping lower

    Northern Star Resources Ltd (ASX:NST) and Whitehaven Coal Ltd (ASX:WHC) shares are two of four dropping lower on Wednesday...

    Read more »

    a woman
    Share Gainers

    Why this cannabis company is smoking the market today

    The THC Global Group Ltd (ASX:THC) share price is zooming higher on Tuesday after the release of a positive announcement...

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis share raced 4% higher on Friday

    The THC Global Group Ltd (ASX:THC) share price was on a high on Friday. Here's why the cannabis company's shares…

    Read more »

    a woman
    Share Gainers

    Why Data#3, Maca, Pact Group, & THC Global shares are storming higher

    The Pact Group Holdings Ltd (ASX:PGH) share price and the THC Global Group Ltd (ASX:THC) share price are two of…

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis company is rocketing 19% higher today

    The THC Global Group Ltd (ASX:THC) share price has returned from its trading halt and stormed higher. Here's why this…

    Read more »

    a woman
    Share Gainers

    Why these ASX cannabis shares are starting the week on a high

    MGC Pharmaceuticals Ltd (ASX:MXC) and THC Global Group Ltd (ASX:THC) are cannabis shares to watch this week. Here's why...

    Read more »

    EPN ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Epsilon Healthcare Ltd

    Epsilon Healthcare Ltd. manufactures and distributes hydroponics equipment, materials, and nutrients; and develops and delivers medical cannabis. The company was founded on August 29, 2016 and is headquartered on Millers Point, Australia.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Alan Preston Beasley Non-Executive DirectorNon-Executive Deputy Chairman Aug 2016
    Mr Beasley has worked in the Investment Banking and Investment Management Industries for over 30 years with BankersTrust Australia, Goldman Sacks Asset Management, BNP Paribas Asset Management Ltd. The last two positions as Managing Director and Australian Country Head. Mr Beasley is a Director and former Director of several listed and unlisted public and private companies including two public charities.
    Mr Peter Giannopoulos Chief Executive OfficerExecutive Director May 2023
    Mr Giannopoulos brings to Epsilon, more than 25 years experience across the Australian healthcare ecosystems including success within the ASX healthcare setting and success in leadership, operations, M&A, GMP manufacturing & the delivery of innovative revenue, and market accretive opportunities Most recently Peter was CEO of Cell Therapies Pty Ltd, an Australian based globally active commercial contract development and manufacturing company with a specialisation in cell and gene therapies and cellular immunotherapy products. At Cell Therapies, Peter introduced corporate strategies and controls and a trajectory for growth, including undertaking capital raising activities to support the organisation to achieve revenue growth in coming years as it capitalises on local and global manufacturing opportunities in the cell and gene therapy landscape. Prior to Cell Therapies Pty Ltd, Peter led the diversification of Australia largest private hospital provider, Ramsay Healthcare (ASX: RHC) as the CEO of the Ramsay Pharmacy Group over a 12 year period. As the executive who developed and led the expansion of the Ramsay Pharmacy Group from a single site in 2007. Peter also has a clinical background with a degree in pharmacy and a deep understanding of the Australian and international health landscapes.
    Ms Zoe Hutchings Non-Executive Director Jun 2024
    --
    Mr Richard Phillip Legge Company Secretary Aug 2024
    -
    Mr Marcelo Mora Company Secretary Dec 2022
    -
    Richard Phillip Legge Company Secretary
    -
    Marcelo Mora Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Watercrest Asset Management Pty Ltd 35,828,878 11.93%
    Fennell Church Pty Ltd 8,438,499 2.81%
    Mr Craig Graeme Chapman <Nampac Discretionary A/C> 7,500,000 2.50%
    Health360 Investment Management Inc 7,052,880 2.35%
    Cannim Group Pty Ltd 5,555,556 1.85%
    Filmrim Pty Ltd 4,465,755 1.49%
    Barcoo Holdings Pty Ltd <Wyan Family Investments> 3,795,824 1.26%
    Karantzias Investments Pty Ltd <Karantzias Family A/C> 3,636,364 1.21%
    Sckld Investments Pty Ltd <Sckld Holdings A/C> 3,593,894 1.20%
    Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 3,055,650 1.02%
    Mr George Daaboul 3,000,000 1.00%
    Meta Growth Corp 2,942,489 0.98%
    Celtic Capital Pty Ltd 2,888,872 0.96%
    Tiger Pty Ltd <Tiger Commercial Unit Trust> 2,545,455 0.85%
    Barcoo Holdings Pty Ltd <Maple Ventures> 2,438,341 0.81%
    Htgr Investments Pty Ltd 2,298,765 0.77%
    Mrs Chongna Wang 2,046,035 0.68%
    Mr Alan Roseby Barkas + Mrs Lee Margaret Barkas <Barkas Super 2,000,000 0.67%
    Mr Craig Graeme Chapman <Nampac Discretionary A/C> (i) 1,958,684 0.65%
    Citicorp Nominees Pty Limited 1,598,988 0.53%

    Profile

    since

    Note